Free Trial

Neoleukin Therapeutics (NLTX) Insider Trading & Ownership

→ FW: 234x Gain (From Weiss Ratings) (Ad)
Free NLTX Stock Alerts
$36.63
+1.24 (+3.50%)
(As of 05/3/2024 ET)
Compare
Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial Media

Neoleukin Therapeutics (NASDAQ:NLTX) Insider Buying and Selling Activity

Current
Insider Ownership
Percentage
1.58%
Number Of
Insiders Buying
(Last 12 Months)
1
Amount Of
Insider Buying
(Last 12 Months)
$1.31 M
Number Of
Insiders Selling
(Last 12 Months)
1
Amount Of
Insider Selling
(Last 12 Months)
$818.40
Get NLTX Insider Trade Alerts

Want to know when executives and insiders are buying or selling Neoleukin Therapeutics stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily.

NLTX Insider Buying and Selling by Quarter

Ad Paradigm Press
Never use this word on your phone (FBI could be watching)
This report sent a chill down my spine. Turns out, as part of their Jan. 6th investigation, the Feds are flagging Americans who typed these ordinary words as part of their banking transactions...
Watch my unredacted video about what I think is coming next right here

Neoleukin Therapeutics Insider and Congressional Trades History

Export to Excel
Transaction DateNameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionDetails
8/17/2023Bros. Advisors Lp BakerDirectorBuy8,347$13.80$115,188.60  
8/15/2023Bros. Advisors Lp BakerDirectorBuy94,440$12.60$1,189,944.00  
8/11/2023Sean Michael SmithCFOSell66$12.40$818.40  
(Data available from 1/1/2013 forward)

NLTX Insider Trading Activity - Frequently Asked Questions

Who is on Neoleukin Therapeutics's Insider Roster?

The list of insiders at Neoleukin Therapeutics includes Bros. Advisors Lp Baker, Carl Walkey, Jonathan G Drachman, Priti Patel, and Sean Michael Smith. Learn more on insiders at NLTX.

What percentage of Neoleukin Therapeutics stock is owned by insiders?

1.58% of Neoleukin Therapeutics stock is owned by insiders. Learn more on NLTX's insider holdings.

Which Neoleukin Therapeutics insiders have been buying company stock?

The following insider purchased NLTX shares in the last 24 months: Bros. Advisors Lp Baker ($1,305,132.60).

How much insider buying is happening at Neoleukin Therapeutics?

Insiders have purchased a total of 102,787 NLTX shares in the last 24 months for a total of $1,305,132.60 bought.

Which Neoleukin Therapeutics insiders have been selling company stock?

The following insiders have sold NLTX shares in the last 24 months: Priti Patel ($2,594.40), and Sean Michael Smith ($2,442.00).

How much insider selling is happening at Neoleukin Therapeutics?

Insiders have sold a total of 336 Neoleukin Therapeutics shares in the last 24 months for a total of $5,036.40 sold.


More Insider Trading Tools from MarketBeat

Related Companies:
Insider Tracking Tools:
Insider Trading By Country:
Latest Articles:
This page (NASDAQ:NLTX) was last updated on 5/5/2024 by MarketBeat.com Staff

From Our Partners
Biden to Launch “FedNOW” [Move Your Money Now]
Priority Gold
Elon to Transform U.S. Economy?
Porter & Company
Automatic Income (from home)
Awesomely, LLC
The asset beating inflation by 4x
Colonial Metals
Could Your Accounts Be Frozen?
Allegiance Gold
The only AI company you should be looking at
Behind the Markets
The A.I. story nobody is telling you (Read ASAP)
TradeSmith
Have You Seen Elon’s New A.I. Device? (Picture Inside)
InvestorPlace